Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. - sprookjes - yvandenbroek - TriplyDB

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

http://www.wikidata.org/entity/Q34487177

about

Emerging therapeutic targets in esophageal adenocarcinoma Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis.PCDH18 is frequently inactivated by promoter methylation in colorectal cancer.MicroRNA Methylation in Colorectal Cancer.Aberrant DNA Methylation: Implications in Racial Health Disparity.Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.Prognostic Subgroups among Patients with Stage II Colon Cancer Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorec The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.The prognostic yield of biomarkers harvested in chemotherapy-naive stage II colon cancer: can we separate the wheat from the chaff?The Ratio of Hmox1/Nrf2 mRNA Level in the Tumor Tissue Is a Predictor of Distant Metastasis in Colorectal Cancer Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer.MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals.LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer.SUMOylated MAFB promotes colorectal cancer tumorigenesis.Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.Aberrant methylation patterns in colorectal cancer: a meta-analysis.Linking Diet to Colorectal Cancer: The Emerging Role of MicroRNA in the Communication between Plant and Animal Kingdoms.A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.Sodium bisulfite pyrosequencing revealed that developmental exposure to environmental contaminant mixtures does not affect DNA methylation of DNA repeats in Sprague-Dawley rats.Genetics, Genetic Testing, and Biomarkers of Digestive Diseases.FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.Luminally expressed gastrointestinal biomarkers.Genetic and epigenetic markers in colorectal cancer screening: recent advances.Epigenetic modification of TLE1 induce abnormal differentiation in diabetic mice intestinal epithelium.Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.Surveillance strategies for colitis-associated cancer: state of the art and future perspectives.Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.Epigenetic mechanisms in microbial members of the human microbiota: current knowledge and perspectives.Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.Epigenetic biomarkers in colorectal cancer: premises and prospects.Dietary phytochemical PEITC restricts tumor development via modulation of epigenetic writers and erasers.Novel biotechnology approaches in colorectal cancer diagnosis and therapy.Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis.Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.

P2860

Q26751209-F4D88966-EA2E-458F-B411-FA711D743FD2 Q30243864-D329321E-446F-4B4C-83D2-9C8B89F14D22 Q33607418-A6B28280-86BB-41EE-84BC-0933F30CA74C Q33654751-564860F8-67CB-4FAC-AC20-808B979DA97C Q33767601-79D502DC-DA2E-4E81-ADF8-9708096EB1EB Q34538870-7A5F691D-6F70-4D1F-A7DD-85AED5399EC0 Q35998173-1FD2FB79-90F6-4AC0-AB1B-262E84417524 Q36049170-085C18CC-565E-4B42-8A17-D14A0005F903 Q36394208-9144CA70-1C96-4A88-88F1-514C1FFD2980 Q36563705-6A1C4B69-F39E-4126-8745-90489BCCED5F Q36855907-02C92DC0-6EC8-44E4-BF74-DB2D5069FDC3 Q37054795-E3E690DC-E01A-4A49-836A-43F122EC9511 Q37190414-2911F857-FDEA-48B7-9A33-A82BEA9CF2A9 Q37256316-85F49B4F-2522-4866-909E-BF6E339A5B62 Q37479994-8E8A026C-B76E-423E-8DB8-23735374E0E7 Q37631429-CB0BF579-9A70-435C-9022-748964120E16 Q37689033-40678368-C836-46B0-B76C-E3B69DE8A787 Q37692550-A6BD9B6E-0C09-4740-918D-6B064308117C Q37696334-6AC6C94E-A34B-4C1A-BA7A-B22E8F333078 Q37701721-9D2DF5B0-D5A4-415D-9B82-E0D583821C35 Q37706504-3D7A48C2-85D6-495A-874C-D321CA020AE2 Q37737640-E43CA22A-6071-4FD4-9085-41017F98E9CA Q38374979-21927133-AAE4-4906-9B88-4463EB2C035D Q38383972-FCFF97F6-85FE-4511-860A-1EC4C872DEBA Q38577969-0D58B792-7E34-4038-A0DD-A31098D245ED Q38603133-B57CE926-1C45-4EF1-814B-5BCA6111E91A Q38636313-8594746C-D641-480E-A178-AD5E45455E04 Q38676702-85BF6AB5-FECD-4739-B776-FEF2254CF76E Q38696352-D2A21C60-9048-4521-8125-F04C1A50CBC6 Q38707876-B8D694B2-3B03-470B-B9FC-0F4DE0818AF8 Q38748390-4101B142-DFD2-496C-8369-F7BA2E1D48F7 Q38763590-D862CFFC-9AB1-4453-B18B-7CC986CBC741 Q38826542-6961DB2B-1B14-44BA-A5C1-CAFC642CB930 Q38944454-54A83039-883B-44DE-8120-F5DE4540895A Q38973406-D4B39BB5-A114-4772-9323-B357DF572EAF Q38992809-04865147-37C0-4ABC-9378-E78C33D11970 Q39025354-FBABD1A0-63C3-4695-ABF6-31E0D0067F41 Q39151211-07860598-9F45-420B-8089-7CCFB199CB92 Q39261789-133D5AB2-C6CC-4D6E-B10C-1E26FF0A52BB Q39542382-A2D61C78-7AB2-4FEF-9898-09F9DC3DDE13

P2860

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

http://www.wikidata.org/entity/Q34487177

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@ast

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@en

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@nl

type

label

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@ast

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@en

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@nl

prefLabel

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@ast

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@en

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@nl

P1433

Q34487177-577A1759-E70C-416E-860E-849DAD9B62F5

P1476

Q34487177-71A41F29-7366-46AA-B51A-1E2346DD2330

P2093

Q34487177-3A157CB6-71BE-4E75-A8B3-B6E3E92B3016

Q34487177-CA589206-6DFE-4687-8048-67338AF294B6

P2860

Q34487177-0014E98A-8BF7-4C61-A4D5-537461D53148

Q34487177-0099C908-E5C8-4F87-AAA9-488D1C53F763

Q34487177-0118E9FF-3BE7-468E-BA90-E974515BEB89

Q34487177-035FCEA5-DAA8-4F1A-A4E1-004E9D26D447

Q34487177-03725C41-60CB-4A94-9956-A49F28A5C6D3

Q34487177-03AD23BD-179E-4B70-8EB7-86DF11406DFD

Q34487177-044B3E2C-D7B9-4679-92BC-1DA85C58DC1E

Q34487177-04984A21-F81B-47D8-B4D8-A3BCAABD4408

Q34487177-04BA90B3-B956-4B57-BFC0-E8E6EC8C9937

Q34487177-06290FB8-0B23-4E72-824C-E6E41F531F87

P304

Q34487177-29103F03-E2EB-4212-A3BD-0A4020DCBE98

P31

Q34487177-1194F33E-5997-4C20-8127-8FC235938D2A

P356

Q34487177-EE7F12A3-237E-4849-B90D-24E793A48BDD

P407

Q34487177-E8837938-0A06-4AC7-A9F5-35C3978A42DC

P433

Q34487177-BEE962E0-CBDD-4859-AE0D-A17548FEBF2C

P478

Q34487177-FC182966-16B8-4A11-91E9-898320749052

P50

Q34487177-CD89D26C-642C-4DA9-8231-F9F2C3957777

P577

Q34487177-8FE11620-8925-455F-9301-E7E875F91C17

P698

Q34487177-A9F5CCC6-0F1B-4295-A0A7-709D0629ED50

P921

Q34487177-6A16F36E-399A-4103-9199-F5523B9F2DBB

Q34487177-95E0A9A6-6767-49C8-BC4D-44E14EDEB94C

P932

Q34487177-279C7815-87FA-4C8D-A9FD-82ED51CB1746

P356

J.GASTRO.2015.07.011

P1433

Gastroenterology

P1476

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

@en

P2093

William M Grady

http://www.w3.org/2001/XMLSchema#string

Yoshinaga Okugawa

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

miRNA expression in colon polyps provides evidence for a multihit model of colon cancer

Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population

DNA methylation patterns and epigenetic memory

Translating the Histone Code

The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain

An integrated encyclopedia of DNA elements in the human genome

Adjuvant Therapy for completely resected Stage II Colon Cancer

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

P304

1204-1225.e12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2015.07.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26216839

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4589488

http://www.w3.org/2001/XMLSchema#string